Silgan Unicep Packaging Lie
FDA inspection history across 2 sites, 2024 to 2026
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2024: one Form 483; 2026: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2024–26One Form 483 and one warning letter, at Spokane, Washington and Richmond, Virginia.
Cited most
Across all Silgan Unicep Packaging Lie observations on file
- 21 CFR 211.84(d)(2)Testing and approval or rejection of components, drug product containers, and closures3
- 21 CFR 211.165(a)Testing and release for distribution1
- 21 CFR 211.68(b)Automatic, mechanical, and electronic equipment1
The complete Silgan Unicep Packaging Lie file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Richmond, Virginia
One warning letter · 2026
Latest: Warning letter, Oct 5, 2026 →Spokane, Washington
One Form 483 · 2024 · 5 observations
Latest: Form 483, Jun 14, 2024 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-10-05 | Warning letter Warning letter | Richmond, Virginia | — | $99 |
| 2024-06-14 | 483 Form 483 | Spokane, Washington | 5 | $99 |
Investigators on these documents
FEI number 3011913386 · most recent document Oct 5, 2026
About Silgan Unicep Packaging Lie
How many FDA Form 483s has Silgan Unicep Packaging Lie received?
FDA Intel has 1 Form 483 on file for Silgan Unicep Packaging Lie; the most recent is dated Jun 14, 2024.
When was Silgan Unicep Packaging Lie last inspected by FDA?
The most recent FDA inspection document on file for Silgan Unicep Packaging Lie is a Form 483 dated Jun 14, 2024, for the site in Spokane, Washington.
What did FDA cite at Silgan Unicep Packaging Lie?
The regulations cited most in the observations on file for Silgan Unicep Packaging Lie are 21 CFR 211.84(d)(2) (Testing and approval or rejection of components, drug product containers, and closures), 3 times; 21 CFR 211.165(a) (Testing and release for distribution), 1 time; 21 CFR 211.68(b) (Automatic, mechanical, and electronic equipment), 1 time.
Has Silgan Unicep Packaging Lie received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Silgan Unicep Packaging Lie; the most recent is dated Oct 5, 2026.